Stocks
Themes
Market Cap Ranking
Trading Strategies
SEC Filings TLDR
Analysis Reports
Sign in
Loading stock data...
Loading updates and signals...
Back
ATOS
$0.92
+5.75%
Analyze
1M
+22.7%
3M
+4.5%
1Y
-39.1%
Market Cap:
$118.84M
Atossa Genetics Inc
Healthcare | Biotechnology
Atossa Therapeutics, Inc., a clinical-stage biopharmaceutical company, discovers and develops drugs in the areas of oncology and infectious diseases. The company is headquartered in Seattle, Washington.
Click "Analyze" to generate stock analysis
ATOS Price Trend and Signals
ATOS Option Volumes & Open Interests (aggregated)
ATOS Put Call Ratios and IV (aggregated)
ATOS Financials
Signals
News
SEC Filings
Holders
Research Reports
AI Analysis
2025-10-01
Somewhat Bullish
price_signal
Monthly high detected.
2025-09-18
Somewhat Bullish
price_signal
Monthly high detected.
2025-09-12
Somewhat Bullish
price_signal
Monthly high detected.
2025-09-11
Somewhat Bullish
price_signal
Monthly high detected.